Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Chebib

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Neurochemical Research|April 24, 2009
The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in miceSebastian P Fernandez, Michael Nguyen, Tin Thing Yow, et al.
Neuropharmacology|November 14, 2006
(3-Aminocyclopentyl)methylphosphinic acids: novel GABA(C) receptor antagonistsMary Chebib, Jane R Hanrahan, Rohan J Kumar, et al.
Journal of Medicinal Chemistry|June 13, 2013
Γ-aminobutyric acid(C) (GABAC) selective antagonists derived from the bioisosteric modification of 4-aminocyclopent-1-enecarboxylic acid: amides and hydroxamatesKatherine E S Locock, Izumi Yamamoto, Priscilla Tran, et al.
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Neuropharmacology|March 23, 2004
Mutations of the 2' proline in the M2 domain of the human GABAC rho1 subunit alter agonist responsesJane E Carland, Allison M Moore, Jane R Hanrahan, et al.
Pharmacological Research|November 26, 2018
Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometryDinesh C Indurthi, Taima Qudah, Vivian W Liao, et al.
Biochemical Pharmacology|February 20, 2014
Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1Dinesh C Indurthi, Elena Pera, Hye-Lim Kim, et al.
ACS Chemical Neuroscience|September 29, 2012
Differentiating enantioselective actions of GABOB: a possible role for threonine 244 in the binding site of GABA(C) ρ(1) receptorsIzumi Yamamoto, Nathan Absalom, Jane E Carland, et al.
Journal of Medicinal Chemistry|June 6, 2008
Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationshipsRohan J Kumar, Mary Chebib, David E Hibbs, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and PharmacologyNavnath Gavande, Izumi Yamamoto, Noeris K Salam, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Neurochemical Research|April 24, 2009
The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in miceSebastian P Fernandez, Michael Nguyen, Tin Thing Yow, et al.
Neuropharmacology|November 14, 2006
(3-Aminocyclopentyl)methylphosphinic acids: novel GABA(C) receptor antagonistsMary Chebib, Jane R Hanrahan, Rohan J Kumar, et al.
Journal of Medicinal Chemistry|June 13, 2013
Γ-aminobutyric acid(C) (GABAC) selective antagonists derived from the bioisosteric modification of 4-aminocyclopent-1-enecarboxylic acid: amides and hydroxamatesKatherine E S Locock, Izumi Yamamoto, Priscilla Tran, et al.
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Neuropharmacology|March 23, 2004
Mutations of the 2' proline in the M2 domain of the human GABAC rho1 subunit alter agonist responsesJane E Carland, Allison M Moore, Jane R Hanrahan, et al.
Pharmacological Research|November 26, 2018
Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometryDinesh C Indurthi, Taima Qudah, Vivian W Liao, et al.
Biochemical Pharmacology|February 20, 2014
Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1Dinesh C Indurthi, Elena Pera, Hye-Lim Kim, et al.
ACS Chemical Neuroscience|September 29, 2012
Differentiating enantioselective actions of GABOB: a possible role for threonine 244 in the binding site of GABA(C) ρ(1) receptorsIzumi Yamamoto, Nathan Absalom, Jane E Carland, et al.
Journal of Medicinal Chemistry|June 6, 2008
Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationshipsRohan J Kumar, Mary Chebib, David E Hibbs, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and PharmacologyNavnath Gavande, Izumi Yamamoto, Noeris K Salam, et al.
Pageof 13